Literature DB >> 10420860

Systematic review of antihypertensive therapies: does the evidence assist in choosing a first-line drug?

J M Wright1, C H Lee, G K Chambers.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10420860      PMCID： PMC1232645     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  24 in total

1.  A meta-analysis of outcome trials in elderly hypertensives.

Authors:  L Thijs; R Fagard; P Lijnen; J Staessen; R Van Hoof; A Amery
Journal:  J Hypertens       Date:  1992-10       Impact factor: 4.844

2.  Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). A randomized controlled trial.

Authors:  N O Borhani; M Mercuri; P A Borhani; V M Buckalew; M Canossa-Terris; A A Carr; T Kappagoda; M V Rocco; H W Schnaper; J R Sowers; M G Bond
Journal:  JAMA       Date:  1996-09-11       Impact factor: 56.272

3.  Morbidity and mortality in the Systolic Hypertension in the Elderly Program (SHEP) pilot study.

Authors:  H M Perry; W M Smith; R H McDonald; D Black; J A Cutler; C D Furberg; M R Greenlick; L H Kuller; H W Schnaper; J A Schoenberger
Journal:  Stroke       Date:  1989-01       Impact factor: 7.914

4.  Drug treatment of hypertension in the elderly: a meta-analysis.

Authors:  J T Insua; H S Sacks; T S Lau; J Lau; D Reitman; D Pagano; T C Chalmers
Journal:  Ann Intern Med       Date:  1994-09-01       Impact factor: 25.391

5.  New meta-analysis of treatment trials of hypertension: improving the estimate of therapeutic benefit.

Authors:  F Gueyffier; A Froment; M Gouton
Journal:  J Hum Hypertens       Date:  1996-01       Impact factor: 3.012

Review 6.  Hypertension in the elderly. Implications and generalizability of randomized trials.

Authors:  C D Mulrow; J A Cornell; C R Herrera; A Kadri; L Farnett; C Aguilar
Journal:  JAMA       Date:  1994-12-28       Impact factor: 56.272

7.  The CASTEL project (CArdiovascular STudy in the ELderly): protocol, study design, and preliminary results of the initial survey.

Authors:  E Casiglia; P Spolaore; P Mormino; O Maschio; G Colangeli; L Celegon; G Maggiolo; L Tittoto; A Pasinato; G B Ambrosio
Journal:  Cardiologia       Date:  1991-07

8.  Low-dose antihypertensive treatment with a thiazide diuretic is not diabetogenic. A 10-year controlled trial with bendroflumethiazide.

Authors:  G Berglund; O Andersson; B Widgren
Journal:  Acta Med Scand       Date:  1986

9.  Long-term mortality after 5-year multifactorial primary prevention of cardiovascular diseases in middle-aged men.

Authors:  T E Strandberg; V V Salomaa; V A Naukkarinen; H T Vanhanen; S J Sarna; T A Miettinen
Journal:  JAMA       Date:  1991-09-04       Impact factor: 56.272

10.  Effect of two different therapeutic approaches on total and cardiovascular mortality in a Cardiovascular Study in the Elderly (CASTEL).

Authors:  E Casiglia; P Spolaore; A Mazza; G Ginocchio; G Colangeli; C Onesto; G Di Menza; L Pegoraro; G B Ambrosio
Journal:  Jpn Heart J       Date:  1994-09
View more
  34 in total

Review 1.  Observational studies of antihypertensive medication use and compliance: is drug choice a factor in treatment adherence?

Authors:  K A Payne; S Esmonde-White
Journal:  Curr Hypertens Rep       Date:  2000-12       Impact factor: 5.369

Review 2.  What are the elements of good treatment for hypertension?

Authors:  C D Mulrow; M Pignone
Journal:  BMJ       Date:  2001-05-05

3.  Why is calling an ACE an ACE so controversial? Evaluating reference-based pricing in British Columbia.

Authors:  Aslam Anis
Journal:  CMAJ       Date:  2002-03-19       Impact factor: 8.262

4.  Antihypertensive drug therapy in the third millennium: are there benefits beyond blood pressure?

Authors:  S E Bakir; S Oparil
Journal:  Curr Hypertens Rep       Date:  2000-06       Impact factor: 5.369

Review 5.  Choosing a first-line drug in the management of elevated blood pressure: what is the evidence? 2: Beta-blockers.

Authors:  J M Wright
Journal:  CMAJ       Date:  2000-07-25       Impact factor: 8.262

Review 6.  CT screening: a trade-off of risks, benefits, and costs.

Authors:  M G Myriam Hunink; G Scott Gazelle
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

7.  Preventing coronary heart disease: high baseline risk strategy and cost effectiveness of guidelines.

Authors:  D Graham Mackenzie; John Forbes; Sarah Wild; Philip Rutledge
Journal:  BMJ       Date:  2006-04-01

Review 8.  Primary and secondary prevention of stroke by antihypertensive treatment in clinical trials.

Authors:  Guido Grassi; Francesca Arenare; Fosca Quarti Trevano; Raffaella Dell'Oro; And Giuseppe Mancia
Journal:  Curr Hypertens Rep       Date:  2007-08       Impact factor: 5.369

Review 9.  Choosing a first-line drug in the management of elevated blood pressure: what is the evidence? 3: Angiotensin-converting-enzyme inhibitors.

Authors:  J M Wright
Journal:  CMAJ       Date:  2000-08-08       Impact factor: 8.262

10.  Failure of psychological interventions to lower blood pressure: a randomized controlled trial.

Authors:  Marco I Perez; Wolfgang Linden; Thomas Perry; Lorri J Puil; James M Wright
Journal:  Open Med       Date:  2009-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.